ResearcherNankai UniversityActive in the last 2 years
Yahui Ding
Matched on ORCID iD 0000-0001-8588-7728; OpenAlex author ID A5084175628, A5125584035. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 7
- Identification of a Small Molecule as Potential Hypoxia-Selective Agents by Reducing Membrane Localization of ENO1 in Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.jmedchem.5c03550↗
- BE-43547A2 exerts hypoxia-selective inhibition on human pancreatic cancer cells through targeting eEF1A1 and disrupting its association with FoxO1. Last author DOI 10.1038/s41401-024-01461-y↗
- Disruption of the sorcin‒PAX5 protein‒protein interaction induces ferroptosis by promoting the FBXL12-mediated ubiquitination of ALDH1A1 in pancreatic cancer. Co-author DOI 10.1186/s13045-025-01680-8↗
- A Two-Phase Approach to Fusicoccane Synthesis To Uncover a Compound That Reduces Tumourigenesis in Pancreatic Cancer Cells. Co-author DOI 10.1002/anie.202117476↗
- Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-43547A2. Co-author DOI 10.1002/anie.202206953↗
- Syntheses and anti-pancreatic cancer activities of rakicidin A analogues. Co-author DOI 10.1016/j.ejmech.2018.03.078↗
- Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells. First author DOI 10.1002/anie.201709744↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tianyang Chen · 3 shared papers, 2022–2026 · strength 0.72
- Paper Identification of a Small Molecule as Potential Hypoxia-Selective Agents by Reducing Membrane Localization of ENO1 in P… DOI 10.1021/acs.jmedchem.5c03550↗
- Paper Disruption of the sorcin‒PAX5 protein‒protein interaction induces ferroptosis by promoting the FBXL12-mediated ubiquiti… DOI 10.1186/s13045-025-01680-8↗
- Paper Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-4… DOI 10.1002/anie.202206953↗
- Yue Chen · 5 shared papers, 2017–2025 · strength 0.68
- Paper BE-43547A2 exerts hypoxia-selective inhibition on human pancreatic cancer cells through targeting eEF1A1 and disrupting… DOI 10.1038/s41401-024-01461-y↗
- Paper A Two-Phase Approach to Fusicoccane Synthesis To Uncover a Compound That Reduces Tumourigenesis in Pancreatic Cancer Ce… DOI 10.1002/anie.202117476↗
- Paper Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-4… DOI 10.1002/anie.202206953↗
- Can Liu · 2 shared papers, 2022–2025 · strength 0.39
- Paper BE-43547A2 exerts hypoxia-selective inhibition on human pancreatic cancer cells through targeting eEF1A1 and disrupting… DOI 10.1038/s41401-024-01461-y↗
- Paper Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-4… DOI 10.1002/anie.202206953↗
- Quan Zhang · 1 shared paper, 2026 · strength 0.29
- Yuehua Chen · 1 shared paper, 2026 · strength 0.29
- Quan Zhang · 1 shared paper, 2025 · strength 0.28
- Yuanjun Sun · 2 shared papers, 2017–2022 · strength 0.21
- Bolin Chen · 1 shared paper, 2022 · strength 0.16
- Jian Chen · 1 shared paper, 2018 · strength 0.07
- Quan Zhang · 1 shared paper, 2018 · strength 0.07
- Juan Yang · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.